MMSL 2014, 83(3):114-119 | DOI: 10.31482/mmsl.2014.021

DEOXYNIVALENOL: METABOLISM AND REGIONAL DIFFERENCES IN HUMAN EXPOSUREReview article

Qing-Hua Wu1,2,3*, Guang-Xu Wu1, Yun Wang1, Dan Wan3, Xiu-Juan Zhang4, Zong-Hui Yuan3

Deoxynivalenol (DON) is one of the most abundant mycotoxins in contaminated food and feed worldwide. It is toxic to humans and inhibits DNA, RNA and protein synthesis. In this review, the metabolism of DON and its exposure in humans from different regions are summarized. Conjugated products DON-3-glucuronide, DON-15-glucuronide, and DON-7-glucuronide are found to be the major metabolites in humans. Human exposure of DON shows some regional differences due to the different DON levels in cereal-based foods and the food intake habits. C12,13-deepoxy metabolite, DOM-1 can be found in most French populations but is rarely detected in UK adults. Spanish exposes lower DON levels than the UK populations. A very high DON exposure is detected in South Africa and Linxian, China. Fetus is shown to expose to DON during pregnancy in human. This review will provide global information of DON metabolism and exposure in humans and facilitate the mycotoxin control strategies.

Keywords: Deoxynivalenol; DON; metabolism; human; exposure; DON-3-glucuronide; DON-15-glucuronide

Received: June 18, 2014; Revised: July 7, 2014; Published: September 5, 2014  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Wu, Q., Wu, G., Wang, Y., Wan, D., Zhang, X., & Yuan, Z. (2014). DEOXYNIVALENOL: METABOLISM AND REGIONAL DIFFERENCES IN HUMAN EXPOSURE. MMSL, 83(3), 114-119. doi: 10.31482/mmsl.2014.021
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Berthiller F, Krska R, Domig KJ, Kneifel W, Juge N, Schuhmacher R, Adam G. Hydrolytic fate of deoxynivalenol-3-glucoside during digestion. Toxicol Lett. 2011, 206(3), 264-267. Go to original source... Go to PubMed...
    2. Bouaziz C, Martel C, Sharaf el dein O, Abid-Essefi S, Brenner C, Lemaire C, Bacha H. Fusarial toxin-induced toxicity in cultured cells and in isolated mitochondria involves PTPCdependent activation of the mitochondrial pathway of apoptosis. Toxicol Sci, 2009, 110(2), 363-375 Go to original source... Go to PubMed...
    3. CAST. 2003. Potential economic costs of mycotoxins in the United States. In: Mycotoxins: risks in plant, animal, and human systems. Task Force Report No. 139. Ames (IA): Council for Agricultural Science and Technology. p. 136-142.
    4. Eriksen GS, Pettersson H, Lindberg JE. Absorption, metabolism, and excretion of 3-acetyl DON in pigs. Arch Anim Nutr. 2003, 57, 335-345. Go to original source... Go to PubMed...
    5. Eriksen GS, Pettersson H. Lake of de-epoxidation of type B trichothecenes in incubates with human faeces. Food Addit Contam. 2003, 20, 579-582. Go to original source... Go to PubMed...
    6. Eriksen GS, Pettersson H, Lundh T. Comparative cytotoxicity of deoxynivalenol, nivalenol, their acetylated derivatives and deepoxy metabolites. Food Chem Toxicol. 2004, 42, 619-624. Go to original source... Go to PubMed...
    7. Gratz SW, Duncan G, Richardson AJ. The human fecal microbiota metabolizes deoxynivalenol and deoxynivalenol-3-glucoside and may be responsible for urinary deepoxy-deoxynivalenol. Appl Environ Microbiol. 2013, 79(6), 1821-1825. Go to original source... Go to PubMed...
    8. JECFA. Summary Report of the Seventy-Second Meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA); JECFA: Rome, Italy, 2010; http://www.who.int/foodsafety/chem/summary72_rev.pdf (accessed May 12, 2014).
    9. Kadota T, Furusawa H, Hirano S, Tajima O, Kamata Y, Sugita-Konishi Y. Comparative study of deoxynivalenol, 3-acetyldeoxynivalenol, and 15-acetyldeoxynivalenol on intestinal transport and IL-8 secretion in the human cell line Caco-2. Toxicol in Vitro. 2013, 27(6), 1888-1895. Go to original source... Go to PubMed...
    10. Katika MR, Hendriksen PJ, Shao J, van Loveren H, Peijnenburg A. Transcriptome analysis of the human T lymphocyte cell line Jurkat and human peripheral blood mononuclear cells exposed to deoxynivalenol (DON): New mechanistic insights. Toxicol Appl Pharmacol. 2012, 264(1): 51-64. Go to original source... Go to PubMed...
    11. Königs M, Lenczyk M, Schwerdt G, Holzinger H, Gekle M, Humpf HU. Cytotoxicity, metabolism and cellular uptake of the mycotoxin deoxynivalenol in human proximal tubule cells and lung fibroblasts in primary culture. Toxicology. 2007, 240(1-2), 48-59. Go to original source... Go to PubMed...
    12. Maul R, Warth B, Kant JS, Schebb NH, Krska R, Koch M, Sulyok M. Investigation of the hepatic glucuronidation pattern of the Fusarium mycotoxin deoxynivalenol in various species. Chem Res Toxicol. 2012, 25(12), 2715-2717. Go to original source... Go to PubMed...
    13. Meky FA, Turner PC, Ashcroft AE, Miller JD, Qiao YL, Roth MJ, Wild CP. Development of a urinary biomarker of human exposure to deoxynivalenol. Food Chem Toxicol. 2003, 41(2), 265-273. Go to original source... Go to PubMed...
    14. Nielsen JK, Vikström AC, Turner P, Knudsen LE. Deoxynivalenol transport across the human placental barrier. Food Chem Toxicol. 2011, 49(9), 2046-2052. Go to original source... Go to PubMed...
    15. Obol'skiĭ OL, Kravchenko LV, Avren'eva LI, Tutel'ian VA. Effect of dietary selenium on the activity of UDP-glucuronosyltransferases and metabolism of mycotoxin deoxynivalenol in rats. Vopr Pitan. 1998, 4, 18-23
    16. Pestka, J.J. Mechanisms of deoxynivalenol-induced gene expression and apoptosis. Food Addit Contam A, 2008, 25(9), 1128-1140. Go to original source... Go to PubMed...
    17. Pestka JJ. Deoxynivalenol: mechanisms of action, human exposure, and toxiclogical relevance. Arch Toxicol. 2010, 84, 663-679. Go to original source... Go to PubMed...
    18. Prelusky DB, Veira DM, Trenholm HL, Hartin KE. Excretion profiles of the mycotoxin deoxynivalenol following oral and intravenous administration to sheep. Fundam Appl Toxicol. 1986, 6, 356-363. Go to original source... Go to PubMed...
    19. Prelusky DB, Trenholm HL. Tissue distribution of deoxynivalenol in swine dosed intravenously. J Agric Food Chem. 1991, 39, 748-751. Go to original source...
    20. Rubert J, Soriano JM, Mañes J, Soler C. Rapid mycotoxin analysis in human urine: a pilot study. Food Chem Toxicol. 2011, 49(9), 2299-2304. Go to original source... Go to PubMed...
    21. Saint-Cyr MJ, Perrin-Guyomard A, Houe'e P, Rolland J-G, Laurentie M. Evaluation of an oral subchronic exposure of deoxynivalenol on the composition of human gut microbiota in a model of human microbiota-associated rats. PLoS ONE. 2013, 8(11), e80578. Go to original source... Go to PubMed...
    22. Sarkanj B, Warth B, Uhlig S, Abia WA, Sulyok M, Klapec T, Krska R, Banjari I. Urinary analysis reveals high deoxynivalenol exposure in pregnant women from Croatia. Food Chem Toxicol. 2013, 62, 231-237. Go to original source... Go to PubMed...
    23. Shephard GS, Burger HM, Gambacorta L, Gong YY, Krska R, Rheeder JP, Solfrizzo M, Srey C, Sulyok M, Visconti A, Warth B, van der Westhuizen L. Multiple mycotoxin exposure determined by urinary biomarkers in rural subsistence farmers in the former Transkei, South Africa. Food Chem Toxicol. 2013, 62, 217-225. Go to original source... Go to PubMed...
    24. Tukey RH, Strassburg CP. Human UDP-Glucuronosyltransferases: Metabolism, expression, and disease. Annu Rev Pharmacol Toxicol. 2000, 40, 581-616. Go to original source... Go to PubMed...
    25. Turner PC, Rothwell JA, White KL, Gong Y, Cade JE, Wild CP. Urinary deoxynivalenol is correlated with cereal intake in individuals from the United kingdom. Environ Health Perspect. 2008, 116(1), 21-25. Go to original source... Go to PubMed...
    26. Turner PC, White KL, Burley VJ, Hopton RP, Rajendram A, Fisher J, Cade JE, Wild CP. A comparison of deoxynivalenol intake and urinary deoxynivalenol in UK adults. Biomarkers. 2010a, 15(6), 553-562. Go to original source... Go to PubMed...
    27. Turner PC, Hopton RP, Lecluse Y, White KLM, Fisher J, Lebailly P. Determinants of urinary deoxynivalenol and de-epoxy deoxynivalenol in male farmers from normandy, France. J Agric Food Chem. 2010b, 58, 5206-5212. Go to original source... Go to PubMed...
    28. Turner PC, Ji BT, Shu XO, Zheng W, Chow WH, Gao YT, Hardie LJ. A biomarker survey of urinary deoxynivalenol in China: the Shanghai Women's Health Study. Food Addit Contam Part A. 2011a, 28(9), 1220-1223. Go to original source... Go to PubMed...
    29. Turner PC, Hopton RP, White KLM, Fisher J, Cade JE, Wild CP. Assessment of deoxynivalenol metabolite profiles in UK adults. Food Chem Toxicol, 2011b, 49 (1), 132-135. Go to original source... Go to PubMed...
    30. Warth B, Sulyok M, Berthiller F, Schuhmacher R, Fruhmann P, Hametner C, Adam G, Fröhlich J, Krska R. Direct quantification of deoxynivalenol glucuronide in human urine as biomarker of exposure to the Fusarium mycotoxin deoxynivalenol. Anal Bioanal Chem. 2011, 401(1), 195-200. Go to original source... Go to PubMed...
    31. Warth B, Sulyok M, Fruhmann P, Berthiller F, Schuhmacher R, Hametner C, Adam G, Fröhlich J, Krska R. Assessment of human deoxynivalenol exposure using an LC-MS/MS based biomarker method. Toxicol Lett. 2012, 211(1), 85-90. Go to original source... Go to PubMed...
    32. Warth B, Sulyok M, Berthiller F, Schuhmacher R, Krska R. New insights into the human metabolism of the Fusarium mycotoxins deoxynivalenol and zearalenone. Toxicol Lett. 2013, 220(1), 88-94. Go to original source... Go to PubMed...
    33. Wu Q, Dohnal V, Huang L, Kuca K, Yuan Z. Metabolic pathways of trichothecenes. Drug Metab Rev. 2010, 42(2), 250-267. Go to original source... Go to PubMed...
    34. Wu Q, Lohrey L, Cramer B, Yuan Z, Humpf HU. Impact of physicochemical parameters on the decomposition of deoxynivalenol during extrusion cooking of wheat grits. J. Agric. Food Chem. 2011, 59, 12480-12485. Go to original source... Go to PubMed...

    Return to the content